Beyond Potency: Emerging Determinants and Optimization Strategies Enhancing Therapeutic Efficacy of Adult Stem Cells

ABSTRACT

Adult stem cell therapies are advancing, yet inconsistent clinical benefit indicates that in vitro potency only partially predicts in vivo performance. Framing efficacy through a systems lens, this review integrates three interlocking levers: (i) cell‐intrinsic programs (tissue imprint, transcriptional/epigenetic state, senescence and metabolic fitness), (ii) microenvironmental constraints and designable cues, and (iii) pre‐ and post‐delivery engineering interventions. We highlight how spatially organized biofabrication—especially 3D bioprinting that tunes geometry, stiffness, and factor presentation—converts a simple cell infusion into an architected niche that stabilizes survival, aligns angiogenesis, and accelerates functional integration. We also synthesize optimization levers spanning biochemical/cytokine licensing, hypoxic and mechanical conditioning, genetic/epigenetic programming, and extracellular‐vesicle–centered strategies; exemplar platforms show that 3D culture and printing can amplify small EV yield and pro‐regenerative content, translating to enhanced vascularization and repair in vivo. Translationally, early‐ and mid‐phase studies show adult stem cells —particularly MSCs—are broadly deliverable with acceptable safety; however, heterogeneity in sourcing, manufacture, dose/route, endpoints, and follow‐up undermines comparability, meta‐analysis, and payer confidence. We outline a path toward adequately powered, multicenter randomized trials under harmonized controls and mechanism‐linked potency assays with standardized clinical and biomarker endpoints. Finally, we examine the regulatory architecture: divergent definitions (manipulation, homologous use), GMP/GTP interpretations, and registry opacity enable uneven evidentiary thresholds and, at times, unregulated offerings—conditions that demand convergence on technical standards, explicit oversight transparency, and risk‐based enforcement. Throughout, mesenchymal stem/stromal cells (MSCs) serve as the principal exemplar of adult stem cells, with other adult stem cell populations cited to show that these principles generalize across cell types.